top of page
Psychedelic Research in the Land
Discover how you can get involved in Cleveland's clinical trials right here! Your participation can make a significant difference in advancing medical research and improving patient care. Join us in this important journey towards groundbreaking discoveries!
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD) or Idiopathic Pulmonary Fibrosis (IPF) as compared to active-placebo.
Contact information for Ohio: anne-marie.duchemin@osumc.edu
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Generalized Anxiety Disorder
Contact information for Ohio: psychresearch@ccf.org
bottom of page